Targeting phosphorylation of STAT3 delays tumor growth in HPV-negative anal squamous cell carcinoma mouse model
Abstract Although conventional chemoradiotherapy is effective for most anal squamous cell carcinoma (ASCC) patients, HPV-negative ASCC patients respond poorly to this treatment and new therapeutic approach is required. Our group has previously established an HPV-negative ASCC mouse model and demonst...
Guardado en:
Autores principales: | Lin-Lin Bu, Yi-Cun Li, Guang-Tao Yu, Jian-Feng Liu, Wei-Wei Deng, Wen-Feng Zhang, Lu Zhang, Zhi-Jun Sun |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/cb4ba309a10049e4a9ed6449710f706e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Episomal HPV16 responsible for aggressive and deadly metastatic anal squamous cell carcinoma evidenced in peripheral blood
por: Hélène Péré, et al.
Publicado: (2021) -
Anal, penile, and oral high-risk HPV infections and HPV seropositivity in HIV-positive and HIV-negative men who have sex with men.
por: Vera M van Rijn, et al.
Publicado: (2014) -
Synergistic effect of cisplatin chemotherapy combined with fractionated radiotherapy regimen in HPV-positive and HPV-negative experimental pharyngeal squamous cell carcinoma
por: Simona Kranjc Brezar, et al.
Publicado: (2020) -
HPV genotyping and risk factors for anal high-risk HPV infection in men who have sex with men from Toronto, Canada
por: Yoojin Choi, et al.
Publicado: (2021) -
Assessing survival rate of HPV-positive and HPV-negative cervical cancer patients
por: M. K. Ibragimova, et al.
Publicado: (2019)